piracetam has been researched along with Anoxia, Brain in 29 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, because the effects seemed dose-related, the dosage of piracetam needed to be increased until the optimum effects were obtained." | 5.35 | [Effects of piracetam therapy in a case of Lance-Adams syndrome]. ( Hachiya, Y; Hanafusa, Y; Hoshino, A; Kumada, S; Kurihara, E; Okiyama, R; Tomita, S; Yokochi, F, 2009) |
| "Piracetam was given at a dose level of 800 mg t." | 2.69 | Dose-effect relationship of idebenone in an experimental cerebral deficit model. Pilot study in healthy young volunteers with piracetam as reference drug. ( Hadler, D; Schaffler, K; Stark, M, 1998) |
| "Piracetam was applicated to 17 patients in the beginning of cervix dilatation, whereas the other patients got Laevulose as a placebo infusion." | 2.65 | [The protective effect of piracetam during delivery]. ( Grosspietzsch, R; Klink, F; Oberheuser, F; von Klitzing, L, 1979) |
| "Since surgery is believed to aggravate cerebral hypoxia and the consequent neurological dysfunction, patients undergoing surgery for brain tumours or ruptured cerebral aneurysms were studied." | 2.64 | Effect of piracetam on level of consciousness after neurosurgery. ( Bereen, FJ; Richardson, AE, 1977) |
| " However, because the effects seemed dose-related, the dosage of piracetam needed to be increased until the optimum effects were obtained." | 1.35 | [Effects of piracetam therapy in a case of Lance-Adams syndrome]. ( Hachiya, Y; Hanafusa, Y; Hoshino, A; Kumada, S; Kurihara, E; Okiyama, R; Tomita, S; Yokochi, F, 2009) |
| "Post-anoxic myoclonus is a rare movement disorder manifested by diffuse action-triggered jerking movements that may result in significant disability." | 1.33 | Post-anoxic myoclonus: a case presentation and review of management in the rehabilitation setting. ( Polesin, A; Stern, M, 2006) |
| "Posthypoxic coma is often associated with cortical and brainstem hyperexcitability." | 1.33 | Levetiracetam suppresses long-loop reflexes at the cortical level. ( Kofler, M, 2006) |
| "A patient presented myoclonus involving all parts of the body after laryngospasm." | 1.32 | [Favorable course of Lance-Adams postanoxic action myoclonus]. ( Benabdejlil, M; Benomar, A; Chkili, T; Errguig, L; Messouak, W; Regragui, W; Yahyaoui, M, 2003) |
| "Levetiracetam appears to be a promising agent for treating action myoclonus caused by hypoxic and encephalitic brain injury-the degree of functional improvement may depend on the severity of associated motor dysfunction." | 1.31 | Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. ( Bergin, A; Cho, YW; Kramer, RE; Krauss, GL; Reich, SG, 2001) |
| "Lance-Adams syndrome is usually recognized only in a late phase, preventing the early rehabilitation." | 1.31 | [Treatment and long-term follow-up of post-anoxic myoclonus]. ( Halász, P; Holló, A; Janszky, J, 2001) |
| "Memory deficits were induced by the muscarinic cholinoceptor antagonist scopolamine (in young and old rats and mice), by the alpha 2-adrenoceptor agonist clonidine, by electroconvulsive shock, and by hypoxy." | 1.29 | Effects of cytidine diphosphate choline on rats with memory deficits. ( Getova, D; Kehayov, RA; Lazarova, MB; Mosharrof, AH; Petkov, VD; Petkov, VV; Vaglenova, J, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (44.83) | 18.7374 |
| 1990's | 3 (10.34) | 18.2507 |
| 2000's | 10 (34.48) | 29.6817 |
| 2010's | 3 (10.34) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Park, KM | 1 |
| Han, YH | 1 |
| Kim, TH | 1 |
| Mun, CW | 1 |
| Shin, KJ | 1 |
| Ha, SY | 1 |
| Park, J | 1 |
| Kim, SE | 1 |
| Cáceres-Agra, JJ | 1 |
| Santana-Cabrera, L | 1 |
| Fernández-Arroyo, M | 1 |
| Sánchez-Palacios, M | 1 |
| Hoshino, A | 1 |
| Kumada, S | 1 |
| Yokochi, F | 1 |
| Hachiya, Y | 1 |
| Hanafusa, Y | 1 |
| Tomita, S | 1 |
| Okiyama, R | 1 |
| Kurihara, E | 1 |
| Venot, M | 1 |
| Weiss, N | 1 |
| Espinoza, S | 1 |
| Imbert, A | 1 |
| Tadie, JM | 1 |
| Fagon, JY | 1 |
| Guerot, E | 1 |
| Diehl, JL | 1 |
| Ko, SB | 1 |
| Ortega-Gutierrez, S | 1 |
| Choi, HA | 1 |
| Claassen, J | 1 |
| Presciutti, M | 1 |
| Schmidt, JM | 1 |
| Badjatia, N | 1 |
| Lee, K | 1 |
| Mayer, SA | 1 |
| Errguig, L | 1 |
| Benomar, A | 1 |
| Messouak, W | 1 |
| Regragui, W | 1 |
| Benabdejlil, M | 1 |
| Yahyaoui, M | 1 |
| Chkili, T | 1 |
| Polesin, A | 1 |
| Stern, M | 1 |
| Kofler, M | 1 |
| Lay-Son Rivas, L | 1 |
| Pizarro Segura, J | 1 |
| Meza Flores, R | 1 |
| Ivanova, IA | 1 |
| Bobkov, IuG | 1 |
| Turova, NF | 1 |
| Ermolina, LA | 1 |
| Baryshnikov, VA | 1 |
| Kopaladze, RA | 1 |
| Aziavchik, AV | 1 |
| Wustmann, C | 3 |
| Fischer, HD | 3 |
| Schmidt, J | 3 |
| Petkov, VD | 1 |
| Kehayov, RA | 1 |
| Mosharrof, AH | 1 |
| Petkov, VV | 1 |
| Getova, D | 1 |
| Lazarova, MB | 1 |
| Vaglenova, J | 1 |
| Schaffler, K | 1 |
| Hadler, D | 1 |
| Stark, M | 1 |
| Krauss, GL | 1 |
| Bergin, A | 1 |
| Kramer, RE | 1 |
| Cho, YW | 1 |
| Reich, SG | 1 |
| Genton, P | 1 |
| Gelisse, P | 1 |
| Janszky, J | 1 |
| Holló, A | 1 |
| Halász, P | 1 |
| Harsha, AB | 1 |
| Pai, N | 1 |
| Shenoy, D | 1 |
| Chakrapani, IM | 1 |
| Bhat, IG | 1 |
| Richardson, AE | 1 |
| Bereen, FJ | 1 |
| Wieck, HH | 1 |
| Geber, J | 1 |
| Marković, Z | 1 |
| Supek, Z | 1 |
| Dupelj, M | 1 |
| Klink, F | 1 |
| Grosspietzsch, R | 1 |
| von Klitzing, L | 1 |
| Oberheuser, F | 1 |
| Dorn, M | 1 |
| Zaffiri, O | 1 |
| Marchetti, G | 1 |
| Vignotto, F | 1 |
| Bonardi, C | 1 |
| Scarella, MR | 1 |
| Godard, JP | 1 |
| Goerens, C | 1 |
| Grelier, C | 1 |
| Chleide, E | 1 |
| Bruhwyler, J | 1 |
| Mercier, M | 1 |
| Berga, P | 1 |
| Beckett, PR | 1 |
| Roberts, DJ | 1 |
| Llenas, J | 1 |
| Massingham, R | 1 |
| Blaschke, M | 1 |
| Rogner, B | 1 |
| Rudolph, E | 1 |
4 trials available for piracetam and Anoxia, Brain
| Article | Year |
|---|---|
Dose-effect relationship of idebenone in an experimental cerebral deficit model. Pilot study in healthy young volunteers with piracetam as reference drug.
Topics: Adult; Antioxidants; Benzoquinones; Dose-Response Relationship, Drug; Electrophysiology; Electroreti | 1998 |
Effect of piracetam on level of consciousness after neurosurgery.
Topics: Brain Neoplasms; Cerebral Cortex; Consciousness; Humans; Hypoxia, Brain; Intracranial Aneurysm; Pira | 1977 |
[The protective effect of piracetam during delivery].
Topics: Adult; Electroencephalography; Female; Fetal Hypoxia; Fetal Monitoring; Humans; Hypoxia, Brain; Infa | 1979 |
[Piracetam in premature biological aging. Double-blind study after preselection by drugs].
Topics: Aged; Aging; Double-Blind Method; Humans; Hypoxia, Brain; Piracetam; Placebos; Progeria; Pyrrolidino | 1978 |
25 other studies available for piracetam and Anoxia, Brain
| Article | Year |
|---|---|
Increased functional connectivity between motor and sensory cortex in a patient with Lance-Adams syndrome.
Topics: Cardiopulmonary Resuscitation; Cerebral Cortex; Electrocardiography; Electroencephalography; Epiglot | 2015 |
[Levetiracetam use in the post-hypoxic myoclonic status].
Topics: Anticonvulsants; Epilepsies, Myoclonic; Humans; Hypoxia, Brain; Levetiracetam; Piracetam; Prospectiv | 2009 |
[Effects of piracetam therapy in a case of Lance-Adams syndrome].
Topics: Adolescent; Anticonvulsants; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Ga | 2009 |
Improvement of early diagnosed post-anoxic myoclonus with levetiracetam.
Topics: Adolescent; Anticonvulsants; Early Diagnosis; Female; Humans; Hypoxia, Brain; Levetiracetam; Male; M | 2011 |
Status epilepticus-induced hyperemia and brain tissue hypoxia after cardiac arrest.
Topics: Aged, 80 and over; Body Temperature; Brain; Cerebrovascular Circulation; Electroencephalography; Hum | 2011 |
[Favorable course of Lance-Adams postanoxic action myoclonus].
Topics: Anticonvulsants; Disease Progression; Electroencephalography; Electrophysiology; Humans; Hypoxia, Br | 2003 |
Post-anoxic myoclonus: a case presentation and review of management in the rehabilitation setting.
Topics: Anticonvulsants; Clonazepam; Diazepam; Female; Heart Arrest; Humans; Hypoxia, Brain; Isoxazoles; Lev | 2006 |
Levetiracetam suppresses long-loop reflexes at the cortical level.
Topics: Coma; Evoked Potentials, Somatosensory; H-Reflex; Humans; Hypoxia, Brain; Levetiracetam; Male; Middl | 2006 |
[Use of levetiracetam in the management of post-anoxic myoclonias. A report of two cases].
Topics: Adult; Anticonvulsants; Humans; Hypoxia, Brain; Levetiracetam; Male; Myoclonus; Piracetam | 2007 |
[Comparative study of several preparations in different models of cerebral hypoxia].
Topics: Animals; Asphyxia; Brain Ischemia; Disease Models, Animal; Drug Evaluation, Preclinical; Electrocard | 1984 |
[Effect of nootropic agents on serum biochemical indices in intellectually deficient children].
Topics: Cerebral Cortex; Child; Female; Fetal Hypoxia; Humans; Hypoxia, Brain; Intellectual Disability; Isoe | 1983 |
The effect of piracetam on posthypoxic dopamine release inhibition.
Topics: Amphetamine; Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Hypoxia, Brain; Male; Piracet | 1982 |
Effects of cytidine diphosphate choline on rats with memory deficits.
Topics: Aging; Animals; Avoidance Learning; Clonidine; Cytidine Diphosphate Choline; Electroshock; Fetal Alc | 1993 |
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
Topics: Adult; Aged; Female; Humans; Hypoxia, Brain; Levetiracetam; Male; Middle Aged; Myoclonus; Piracetam; | 2001 |
Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam.
Topics: Anticonvulsants; Dose-Response Relationship, Drug; Encephalitis; Epilepsies, Myoclonic; Humans; Hypo | 2001 |
[Treatment and long-term follow-up of post-anoxic myoclonus].
Topics: Adult; Cognition Disorders; Depressive Disorder, Major; Female; Humans; Hypoxia, Brain; Myoclonus; N | 2001 |
Piracetam in post-hypoxic action myoclonus.
Topics: Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hypoxia, Brain; Injections, Int | 2001 |
[Therapy with cerebral anti-hypoxidotics].
Topics: Humans; Hypnotics and Sedatives; Hypoxia, Brain; Meclofenoxate; Piracetam; Tranquilizing Agents; Vas | 1979 |
[Piracetam and evoked cortical responses].
Topics: Animals; Cats; Cerebral Cortex; Electrophysiology; Evoked Potentials; Female; Hypoxia, Brain; Male; | 1979 |
[Personal experience with the use of piracetam (Nootropil) in anesthesiology].
Topics: Adjuvants, Anesthesia; Anesthesia, General; Coma; Confusion; Drug Evaluation; Heart Arrest; Humans; | 1977 |
Usefulness of piracetam in intensive care.
Topics: Alcoholism; Brain Diseases; Brain Injuries; Carbon Monoxide Poisoning; Cerebrovascular Disorders; Ch | 1976 |
Enhanced resistance effect of piracetam upon hypoxia-induced impaired retention of fixed-interval responding in rats.
Topics: Animals; Conditioning, Operant; Hypoxia, Brain; Male; Memory; Piracetam; Rats; Rats, Inbred Strains; | 1991 |
Synergistic interactions between piracetam and dihydroergocristine in some animal models of cerebral hypoxia and ischaemia.
Topics: Anesthesia; Animals; Avoidance Learning; Brain Ischemia; Cerebrovascular Circulation; Dihydroergotox | 1986 |
Influence of taurine on the posthypoxic dopamine release inhibition in comparison to piracetam.
Topics: Animals; Corpus Striatum; Dopamine; Hypoxia, Brain; In Vitro Techniques; Piracetam; Rats; Rats, Inbr | 1987 |
Characterization of the antihypoxic activity of tisochromid.
Topics: Animals; Antioxidants; Corpus Striatum; Dopamine; Drug Evaluation, Preclinical; Heterocyclic Compoun | 1985 |